Your browser doesn't support javascript.
loading
The added value of [18F]fluorocholine PET/TC in the assessment of secondary or tertiary hyperparathyroidism.
Abouzian, S; López-Mora, D A; Fernández-León, A; Facundo, C; Stefaneli, P; Flotats, A.
Affiliation
  • Abouzian S; Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. Electronic address: sabouzian@santpau.cat.
  • López-Mora DA; Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Fernández-León A; Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Facundo C; Unidad de Trasplante Renal, Fundación Puigvert, Barcelona, Spain.
  • Stefaneli P; Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Flotats A; Servicio de Medicina Nuclear, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Rev Esp Med Nucl Imagen Mol (Engl Ed) ; 43(3): 500005, 2024.
Article in En | MEDLINE | ID: mdl-38621476
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choline / Radiopharmaceuticals / Hyperparathyroidism, Secondary Limits: Humans Language: En Journal: Rev Esp Med Nucl Imagen Mol (Engl Ed) Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Choline / Radiopharmaceuticals / Hyperparathyroidism, Secondary Limits: Humans Language: En Journal: Rev Esp Med Nucl Imagen Mol (Engl Ed) Year: 2024 Document type: Article